ACKR3 and neoplasm: While these results are not necessarily translatable to tumor vascular dysfunction we believe that, when taken together with our current study in primary human EC and the wealth of histopathological data showing that CXCR7 is highly expressed in tumor vasculature, the potential of CXCR7 as an antiangiogenic target deserves further study.